Romanian-Held Pharmaceutical Manufacturer Antibiotice To Get EUR100M In EU Funding To Make Critical Drugs

06.06.2024 By Georgiana Mihalache

Antibiotice Iasi, (ATB.RO) the largest Romanian-owned pharmaceutical producer, will receive EUR100 million in EU funding for the production of drugs such as antibiotics, for which there are no therapeutic alternatives. The announcement was made in Iasi by the Minister for Investments and European Projects Adrian Caciu, who visited the industrial site.

To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 50 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

 
Keywords:
antibiotice
, funding
, production
, critical
, drug